ReviewDrug design, development and therapy2017

The modulation of enzyme indoleamine 2,3-dioxygenase from dendritic cells for the treatment of type 1 diabetes mellitus.

Débora Moitinho Abram et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.